{"id":"NCT02573311","sponsor":"Boehringer Ingelheim","briefTitle":"Actual Use Study of Tamsulosin in Men","officialTitle":"A 6-month OTC-simulated, Open Label, Uncontrolled Study of Tamsulosin 0.4 mg in Men","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-23","primaryCompletion":"2016-08-01","completion":"2016-08-01","firstPosted":"2015-10-09","resultsPosted":"2020-04-08","lastUpdate":"2020-04-08"},"enrollment":1117,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Urological Manifestations"],"interventions":[{"type":"DRUG","name":"tamsulosin hydrochloride","otherNames":[]}],"arms":[{"label":"men","type":"EXPERIMENTAL"}],"summary":"An actual use study to assess how men who respond to advertisements about urinary symptoms use tamsulosin in a simulated Over the Counter (OTC) setting including following \"stop use and ask a doctor if\" and \"ask a doctor before use\" statements and if they take the medication according to the label instructions, also assess any reported adverse events during simulated OTC use.","primaryOutcome":{"measure":"Percentage of Men Who Report a Condition Listed Under the \"Stop Use and Ask a Doctor if\" Section of the DFL Within the First 12 Weeks of Using Study Product and do Not Stop Use or Initiate Contact With Doctor Out of Total Population in Cohort 1","timeFrame":"12 weeks","effectByArm":[{"arm":"Cohort 1","deltaMin":0.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":40,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":54,"n":927},"commonTop":["Nasopharyngitis","Back pain"]}}